Medically reviewed by Lindsey Waldman, MD, RD A C. diff (Clostridioides difficile ) diet may help alleviate diarrhea (the primary symptom) that is associated with this bacterial infection.

Biosciences' lead drug candidate, VE303, has been reported to demonstrate efficacy in preventing recurrent Clostridioides ...

PureTech Health (PRTC) noted that its founded entity, Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia ...

Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today announced the publication of additional results from ...

Topline data for the ongoing Phase 3 pivotal RESTORATiVE303 study are expected in 2026 ...